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The proopiomelanocortin (POMC) gene and protein are expressed principally in the pituitary and brain (e.g.,
hypothalamus). The POMC gene, protein, and derived peptides, however, can also be detected in the skin. It
appears that POMC can also be processed in the skin, a tissue that also expresses the prohormone convertases
PC1 and PC2 and 7B2 protein. All POMC peptides may be produced in the skin epidermis, dermis, and adnexa by
epithelial cells, melanocytes, and mesenchymal cells (e.g., immune cells, ﬁbroblasts, and endothelial cells), and
can also be released from cutaneous sensory nerve endings (cf. Slominski et al, 2004).
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It has long been known that melanocortins (MSH) and ad-
reno-corticotropins (ACTH) play a fundamental role in the
regulation of melanogenesis. The observed phenotypic ef-
fects of MSH and ACTH peptides in cutaneous melanocytes
are mediated via cell surface receptors (containing seven
transmembrane domains) linked to Gs protein- and cAMP-
dependent pathways. In addition, activation of protein kin-
ase C by a-MSH may also be involved in melanogenesis (cf.
Slominski et al, 2004). Epidermal and dermal cells predom-
inantly express the MC-1R with a high affinity for a-MSH
and ACTH.
A potential role for b-endorphin (b-END) in human
melanogenesis, however, has recently been described by
our laboratory (Kauser et al, 2003, 2004). Hitherto, the con-
sensus was that the only POMC peptides with significant
melanogenic activity were ACTH, a-MSH, and possibly also
b-MSH.
b-END and the Skin
b-END is produced by the cleavage of the b-LPH fragment
by PC2 and binds with high affinity to the opiate receptors
m and d (cf. Slominski et al, 2004), and with low affinity to
k receptors. b-END, like the opioids enkephalins and
dynorphins, mediates its biological actions by activation of
receptors coupled with one of multiple G proteins to reg-
ulate adenylyl cyclase, phosphatidyl-inositol-3 kinase, MAP
kinase pathways, and Ca2þ and Kþ channels. But, opioid
receptors can also exhibit intrinsic activity, even in the ab-
sence of ligand and this can be reversed by opioid antag-
onists.
b-END has been implicated in the pathogenesis of sev-
eral dermatoses, and elevated b-END plasma levels have
been reported in psoriasis, and in atopic dermatitis (cf. Slo-
minski et al, 2004). These associations may be related to b-
ENDs action as a differentiation factor for keratinocytes e.g.
via upregulation of cytokeratin 16 expression. b-END plas-
ma levels are also reported to be higher in patients with the
depigmentation disorder vitiligo, whereas in the skin itself,
b-END expression appears to be higher in lesional versus
uninvolved areas (cf. Slominski et al, 2004). To date, only the
m- and x-opioid receptors have been localized in the skin,
where their expression has been detected in normal epi-
dermal keratinocytes, and in chronic and acute wounds (cf.
Slominski et al, 2004).
b-END and Epidermal Pigmentation
A role for b-END in pigmentation has been suggested by the
increased plasma b-END and b-LPH levels that may occur
after UVA exposure and associated increased skin pigmen-
tation. b-LPH, the immediate precursor of b-END and b-
MSH, can stimulate melanogenesis in sheep, and elevated
serum levels of b-LPH may be associated with generalized
hyperpigmentation in humans.
Recently, we have shown that the b-END/m-opiate re-
ceptor system is prominently expressed in human epider-
mal melanocytes (EM) in situ and in vitro, where the peptide
and its receptor appear to be closely associated with mel-
anin-producing melanosomes (Kauser et al, 2003). Impor-
tantly, treatment of cultured normal EM with b-END results
in increased melanogenesis and proliferation, providing di-
rect evidence that the b-END/m-opiate receptor system is
functionally active in skin melanocytes (Kauser et al, 2003).
Notably, these effects were of a magnitude similar to those
reported for the known melanotropins a-MSH and ACTH
(cf. Slominski et al, 2004). b-END also exerts potent den-
dritogenic effects in EM, where it not only increases pro-
duction of melanized pigment granules but also facilitates
their active transfer to recipient keratinocytes. As both b-
END ligand and m-opiate receptors are detected in EM and
keratinocytes, autocrine and paracrine mechanisms of
Abbreviations: b-END, b-endorphin; EM, epidermal melanocyte;
ORS, outer root sheath; POMC, proopiomelanocortin; PKC, protein
kinase C
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action appear highly likely in the regulation of melanocyte
physiology. In fact, the finding of a positive correlation be-
tween b-END expression and melanocyte differentiation
status (i.e., pigmentation and dendricity) suggests that b-
END expressed by EM may indeed be involved in the mod-
ulation of melanocyte differentiation through autocrine con-
trol. Expression of the m-opiate receptor also correlates
positively with melanocyte differentiation in vitro, supporting
the view that the m-opiate receptor expression may be up-
regulated by its ligand b-END, similar to the binding of a-
MSH to MC-1R (cf. Slominski et al, 2004).
Melanocortins induce melanogenesis by predominantly
activating the cAMP second messenger system (cf. Slo-
minski et al, 2004). By contrast, b-END (like other opioids)
mediate their biological actions while inhibiting this signa-
ling pathway. m-opiate R agonists are known to activate
protein kinase C (PKC), and PKC-b-dependent pathways
are increasingly being implicated in the regulation of
melanogenesis. Recently, it has been reported that micro-
phthalmia-associated transcription factor (for the tyrosinase
gene) regulates PKC-b transcription (cf. Slominski et al,
2004).
b-END and Hair Follicle Pigmentation
The potential significance of POMC peptides in the regu-
lation of human follicular melanocyte biology is much less
well understood than for human EM. Similarly, expression of
the b-END peptide in human follicular cells is still somewhat
controversial. Slominski et al (1993) have reported b-END
immunoreactivity in keratinocytes of the hair follicle kera-
tinocytes in scalp but not truncal skin, and more recently
prominent b-END immunoreactivity has been reported in
the follicular matrix of truncal skin. In neither study, however,
is specific reference made to b-END immunoreactivity in
melanocytes.
b-END and l-opiate receptor are expressed in hair fol-
licle melanocytes during the hair growth cycle We re-
cently reported that b-END immunoreactivity is strongest in
melanogenically active bulbar melanocytes of anagen VI
compared with amelanotic melanocytes or the outer root
sheath (ORS) (Kauser et al, 2004). b-END expression is only
marked in the hair follicle epithelial compartments but is
weakly undetectable in the follicular dermal papilla (FP)
mesenchyme (Fig 1A). b-END immunoreactivity is, however,
detectable during catagen and telogen, not only in the hair
follicle epithelium but also in the catagen FP. This reduction
in FP b-END levels in anagen is contrary to the pattern of the
usual hair cycle-dependent fluctuations in other growth
factors (cf. Stenn and Paus, 2001). Although b-END
immunoreactivity is low in rare non-dendritic melanocytes
in catagen follicles (Fig 1B), b-END expression increased in
melanocytes distributed in the peripheral regions of the ep-
ithelial sac in telogen follicles (Fig 1C). But, the striking up-
regulation of b-END expression in melanogenically active
bulbar melanocytes during anagen VI strongly suggests that
hair follicle melanocytes (HFM) may be an important local
source of this POMC peptide at this stage of the hair cycle,
and may play an important role in the regulation/mainte-
nance of human hair follicle pigmentation. This pattern of
b-END expression may be species specific, as b-END
immunoreactivity in murine skin is found to be confined to
the sebaceous glands throughout the hair growth cycle,
suggesting that the sebaceous gland is a prominent local
source of b-END production in murine skin (cf. Slominski
et al, 2004). These data suggest significant differences in
the regulation of the POMC system in human and murine
hair growth and pigmentation.
Figure 1
Human hair follicle melanocytes express b-endorphin (b-END) during the hair growth cycle. b-END is expressed strongly by melanocytes
located in the bulb and outer root sheath (ORS) of anagen hair follicles (arrowheads) (A). In catagen hair follicles, b-END is expressed by rare
melanocytes in the former bulb matrix area (arrowheads) (B). b-END-positive melanocytes were observed in the epithelial sac and secondary germ
of telogen follicles (arrowheads) (C). Seven micrometer thick cryosections of normal human haired scalp obtained after elective plastic surgery (from
five females, age range 43–60 y, mean age 50 y) or from occipital scalp tissue of two normal healthy males (age 23 and 36 y) were processed for
double immunolabeling as previously described (Kauser et al, 2003) using monoclonal antibodies to b-END and to gp100 (for melanocytes). Scale
bar¼ 50 mm. C, club; ESt, epithelial strand; ESa, epithelial sac; SG, secondary germ. [Reproduced from: Kauser et al (2004).]
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The expression of the m-opiate R also exhibits hair cycle-
dependent fluctuations (Kauser et al, 2004). In marked
contrast to b-END, however, expression of its receptor is
detected during anagen VI only in a small sub-population of
weakly melanogenic melanocytes located both in the prox-
imal/peripheral hair bulb matrix and in amelanotic me-
lanocytes located in the ORS. The FP, hair bulb matrix
keratinocytes, and ORS also exhibited strong m-opiate R
expression (Fig 2A). This observation is in agreement with
the findings of other workers who have also reported m-
opiate R immunoreactivity in human hair follicle ORS (cf.
Slominski et al, 2004). The absence of m-opiate R detection
in melanogenically active bulbar melanocytes is striking and
could be because of low levels of receptor availability for
the anti-m-opiate R antibody because of ligand-receptor
saturation. Alternatively, m-opiate R expression may be
downregulated, as appears to be the case in catagen (Fig
2B) and telogen hair follicles (Fig 2C). Some m-opiate R ex-
pression is detectable in rare non-dendritic melanocytes in
the residual catagen bulb and in melanocytes in the pe-
ripheral regions of the telogen epithelial sac.
The FP mesenchyme and follicular epithelium consist-
ently show prominent m-opiate R expression throughout the
hair cycle. Thus, the presence of the b-END ligand and m-
opiate R in both follicular melanocytes and keratinocytes
suggest that autocrine and paracrine effects may regulate
follicular melanocyte behavior during catagen and telogen
only, as in situ studies failed to detect b-END immunoreac-
tivity in the FP of anagen VI hair follicles. Expression is
detected, however, in isolated FP cells under in vitro con-
ditions. The differences in b-END expression observed
in situ and in vitro could be because of variable peptide
levels dependent on cell differentiation status, or because of
the different detection systems used for the in situ versus
in vitro assays.
b-END and l-opiate receptor are expressed in cultured
HFM Expression of the b-END/m-opiate R system is also
detected in primary cultures of HFM consisting of both ter-
minally differentiated bulbar melanocytes (actively engaged
in melanogenesis) and amelanotic melanocytes (Fig 3).
Strong b-END immunoreactivity is restricted to the peri-nu-
clear region of pigmented melanocytes. But, expression is
reduced/lost from the highly melanized dendrites of these
cells. This distribution pattern suggests that b-END expres-
sion could be associated with early stages in melanosome
biogenesis. This was suggested by immunoelectron mi-
croscopy studies that revealed a close association of b-
END and m-opiate R expression primarily in less mature
stage II and III melanosomes, which represent the early
stages of active melanogenesis (Kauser et al, 2003).
The positive correlation between b-END/m-opiate R ex-
pression and melanocyte differentiation status in culture
suggests autocrine control of melanocyte function by this
system. Given that both the b-END and the m-opiate R are
only expressed in relatively undifferentiated melanocytes of
the ORS and the proximal/peripheral matrix, b-END/m-opi-
ate R signaling may participate particularly in the biology of
these undifferentiated melanocytes. For example, b-END/m-
opiate R signaling may be involved in their migration into the
hair matrix and their subsequent differentiation into pig-
ment-producing cells. In support of this, recent studies have
shown that exogenously supplied b-END stimulates the mi-
gration of cultured human foreskin keratinocytes (cf. Slo-
minski et al, 2004). Amelanotic melanocytes are also found
in the ORS of white hair follicles (Horikawa et al, 1996), and
it has been speculated that the whitening of hair with ad-
vancing age is a consequence of yet unknown factors that
prevent these cells from migrating or maturing into pigment-
producing cells (Tobin and Paus, 2001).
Our functional studies also provide direct evidence for
the existence of a fully active b-END/m-opiate R system in
human HFM (Fig 4). Exogenously supplied b-END stimulat-
ed increased melanogenesis and proliferation in follicular
melanocyte cultures and these effects were comparable
with those observed with b-END (Kauser et al, 2003), a-
MSH, and ACTH (cf. Slominski et al, 2004) stimulation of
EM. Although reports suggest that only opiate ligands that
Figure 2
Human hair follicle melanocytes ex-
press the l-opiate receptor during the
hair growth cycle. m-opiate R is ex-
pressed strongly by a minor sub-popula-
tion of melanocytes located in the
proximal/peripheral matrix region and in
the outer root sheath (ORS) of anagen hair
follicles (arrowheads), but is absent from
melanocytes in the melanogenic zone (A).
In catagen hair follicles, m-opiate R is ex-
pressed by melanocytes in the regressing
epithelial strand, above the FP and by a
population of melanocytes located in the
club surrounding the forming epithelium
(arrowheads) (B). In telogen follicles, small
numbers of m-opiate R-positive me-
lanocytes were observed in the epithelial
sac (arrowheads) (C). Seven micrometer
thick cryosections of normal human
haired scalp obtained after elective plas-
tic surgery (from five females, age range
43–60 y, mean age 50 y) or from occipital
scalp tissue of two normal healthy males (age 23 and 36 y) were processed for double immunolabeling as previously described (Kauser et al, 2003).
using monoclonal antibodies to m-opiate R and to gp100 (for melanocytes) Scale bar¼ 50 mm. [Reproduced from Kauser et al (2004).]
214 TOBIN AND KAUSER JID SYMPOSIUM PROCEEDINGS
bind to the z opiate receptor have growth factor activity, we
have previously shown that the m-opiate R ligand b-END has
significant mitogenic effects on EM (Kauser et al, 2003), and
now also in follicular melanocyte cultures. Thus, this view of
opiate receptor signaling may need to be broadened. The
melanogenic effects of b-END stimulation in follicular me-
lanocytes appeared to correlate with hair color. HFM de-
rived from dark-haired individuals (dark-brown and black)
were the most b-END responsive compared with lighter hair
color. Donor variability in EM responsiveness to a-MSH and
ACTH stimulation is thought to reflect differences in the ex-
tent of peptide binding to the MC-1R and its subsequent
signaling activity (cf. Slominski et al, 2004). Such control
points may also exist in m-opiate R signaling in follicular
melanocytes.
b-END has potent dendritogenic effects in HFM cultures.
Similarly, these effects were greater in melanocytes derived
from dark-haired individuals. Successful transfer of melano-
somes depends both on the number of dendrites per cell
and their length. Both of these parameters are upregulated
by b-END. Therefore, stimulated melanocytes not only pro-
duce more highly melanized pigment granules but they
can potentially transfer these more effectively to recipient
keratinocytes. Interestingly, our data have shown that
HFM cultures that had been initially established in phorbol
ester and cholera toxin-supplemented medium, but then
switched to natural mitogen (endothelin-1/bFGF)-containing
medium, showed a marked reduction in cell dendricity in
response to b-END stimulation, despite the induction of
melanogenesis (Kauser et al, 2003). These effects appeared
to be HFM specific, as they were not observed with
matched EM lines. This finding may relate to the observa-
tion that inclusion of artificial mitogens, such as phorbol
ester, in the culture medium appears to downregulate
Figure 3
Primary cultures of human follicular melanocytes (HFM) express b-endorphin (b-END) and the l-opiate receptor. Each frame pair represents
the same cell population taken with both fluorescence and bright-field microscopy (e.g., A1, A2). The expression of b-END (A1) and the m-opiate R
(B1) is variable in primary HFM cultures. In pigmented bulbar melanocytes expression of b-END is confined to the peri-nuclear region (arrowhead). In
amelanotic melanocytes, it is present throughout the cell body (arrow) (A1, A2). m-Opiate R expression is stronger in highly proliferative amelanotic
melanocytes (arrow) and is downregulated in pigmented bulbar melanocytes (arrowhead) (B1, B2). Gp100-positive staining in both amelanotic
(arrow) and pigmented bulbar melanocytes (arrowhead) confirmed their melanocyte identity (C1, C2). Negative control from which the primary
antibody is omitted (D1, D2). HFM primary cultures were seeded into eight-well Lab-Tek chamber slides at a density of 5000 cells per well and
cultured for 2–3 d. FCS and BPE were omitted from the culture media 48 h before immunostaining. Subsequent steps in immunostaining were
performed by indirect immunofluorescence. Scale bar¼ 17 mm. [Reproduced from Kauser et al (2004).]
Figure 4
Stimulation of melanogenesis and pro-
liferation in follicular melanocytes after
incubation with b-endorphin (b-END).
Melanin content is determined spectro-
photometrically (475 nm) after NaOH
solubilization. Cells with low basal mela-
nin levels showed visible increases in
melanogenesis after b-END stimulation
(A1, A2). This visible change is not ap-
preciable in cells containing high basal
melanin levels (A3). Melanocyte cultures
were grown without FCS and BPE for 48 h
before stimulation with 108 M b-END
(Sigma, Poole, Dorset, UK) for 72 h. Me-
lanocytes from the same donor were
maintained in parallel in the absence of
the peptide and served as a negative
control. Results are expressed as a per-
centage increase in melanin content (A)
and cell number (B) over control unstim-
ulated levels and are a mean  SEM
of seven cell lines. po0.001. [Repro-
duced from Kauser et al (2004).]
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MC-1R expression, thus reducing their a-MSH responsive-
ness (cf. Slominski et al, 2004). Our findings suggest that
phorbol ester and cholera toxin may also affect m-opiate R
function in HFM. Whereas the signaling pathways involved
in melanogenesis stimulation appear to be unaffected,
those inducing cell dendricity seem to be inhibited, sug-
gesting that melanogenic and dendritogenic responses to
b-END are likely to be independent.
Recent evidence suggests that topical application of a
selective PKC inhibitor, bisindolylmaleimide, can reduce
hair length (presumably via anagen truncation) and thick-
ness (presumably via alteration of keratinocyte proliferation/
differentiation) in guinea-pigs and mice in vivo (Park et al,
2004). As PKC may be implicated in keratinocyte differen-
tiation, together with our observed higher levels of b-END
expression in more differentiated keratinocytes, we would
like to propose that b-END may also play an important role
in the modulation of hair growth/cycling.
In conclusion, we propose an important new role for b-
END in the biology of human hair pigmentation. Our data
offer to provide a new research direction to the mechanisms
that regulate human hair pigmentation where POMC pep-
tides could play a major role.
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